NB
Therapeutic Areas
Liberate Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| In Vivo CAR-M Program | B-cell driven autoimmune diseases / Hematologic cancers | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| In Vivo CAR-M Program | B-cell driven autoimmune diseases / Hematologic cancers | Preclinical |